SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : Biotransplant(BTRN) -- Ignore unavailable to you. Want to Upgrade?


To: scaram(o)uche who wrote (278)6/3/1999 10:02:00 AM
From: LLCF  Read Replies (1) | Respond to of 1475
 
< BGEN seems to be really rolling with anti-CD40L, while MEDI doesn't seen to be spreading 507 over many indications.>

Yes, I've seen you post this a few times... I did post something somewhere the other day about an article touting MEDI, and someone from MEDI mentioning 507, so at least it's on their radar. Wonder why that is that they arent talking much... BTRN getting down to buy range again.

DAK



To: scaram(o)uche who wrote (278)6/3/1999 3:53:00 PM
From: nigel bates  Read Replies (1) | Respond to of 1475
 
>>Don't understand the heavy emphasis on RGEN in the article<<

Could be something to do with the company press release ...

biz.yahoo.com

nig